ÃØÃÜÑо¿Ëù

Internal Server Error
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!
Signup and get free access

Last updated:

About Aisling Capital

Aisling Capital is a private equity firm founded in 2000.ÌýIt is primarily based in New York City, United States.ÌýIn the last 12 months, it has participated in 2 funding rounds.Ìý
A lot of funds co-invest with Aisling Capital, with names like Orbimed sharing a substantial percentage of its portfolio.Ìý
Aisling Capital has a team of 16 people, including 8 partners.
Key Metrics
Founded Year
2000
Location
New York City, United States
Investment Deals
BridgeBio, GileadÌý&²¹³¾±è;Ìý

Aisling Capital's Portfolio

They have invested in a total of 127 companies. Their most recent investment was in Marker Therapeutics (Post IPO round) on Dec 19, 2024.

Team profile of Aisling Capital

Aisling Capital has a team of 16 membersÌý¾±²Ô³¦±ô³Ü»å¾±²Ô²µ 8 Partners, 1 Venture Partner and 6 PrincipalsÌýlocated in United States. Aisling Capital's team does not sit on the board of any company as of now.
Here is a list of top team members in Aisling Capital:
Name
Designation
Location
Board Memberships
Contact details
Partner
New York City
-
Partner
New York City
-
Partner
New York City
-
Partner
New York City
-
Partner
New York City
-
Partner
New York City
-
Partner
Radnor
-
Partner
New York City
-
Venture Partner
New York City
-
-
Principal
New York City
-
Principal
New York City
-

Co-investors of Aisling Capital

Over the past 25 years, 160 investors have co-invested in Aisling Capital's portfolio companies.

  • Top Co-investors of Aisling Capital:Ìý160 investors entered a company along with Aisling Capital. These include investors like Orbimed (8 companies).

Aisling Capital News

•
MarketBeat•Apr 03, 2025•OnKure Therapeutics, Aisling Capital
•
Precision Oncology News•May 02, 2024•BridgeBio, Omega Funds, Deerfield, Google Ventures and 8 others
•
Pharmaceutical Technology•Dec 12, 2023•Braidwell, TPG, Deerfield, Fairmont and 4 others
•
Silicon Valley Journals•Dec 12, 2023•Bicara Therapeutics, Red Tree Venture Capital, RA Capital Management, F-Prime Capital and 13 others
•
Silicon Canals•Aug 17, 2023•COMPASS Pathways, TCG Crossover, Aisling Capital, Vivo Capital and 10 others
•
FinSMEs•Feb 08, 2023•Garuda, Northpond Ventures, Orbimed, Cormorant Capital and 5 others
•
Business Wire•Sep 12, 2022•Forge Biologics, Drive Capital, Aisling Capital
•
Fierce Biotech•Jun 14, 2022•Dren Bio, Pfizer, Aisling Capital, HBM Healthcare Investments and 8 others
•
Business Wire•Mar 29, 2022•Shorla Oncology, Aisling Capital
•
Barron's•Feb 02, 2022•Harris Williams, , Novo Holdings, Aisling Capital
Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
  • check icon 4M+ Companies
  • check icon 212K+ Investors
  • check icon 580K+ Funding Rounds
  • check icon 207K+ Acquisitions
  • check icon 2.9K+ Sectors
  • check icon 57K+ Business Models

Accel PartnersPartechIN-Q-TEL - USPalo Alto NetworkMaersk GrowthFujitsuTenityStanford
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!Signup and get free accessÌýarrow-right-long